<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00410000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q16611</UniProt_ID>
  <Seq_Length>211</Seq_Length>
  <Molecule_Weight>23409</Molecule_Weight>
  <KEGG_ID>hsa:578</KEGG_ID>
  <Orthology_ID>K14021</Orthology_ID>
  <EBI_ID>EBI-519866</EBI_ID>
  <Function_Summary>In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti-apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis.</Function_Summary>
  <Pfam_ID>PF00452:Bcl-2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Bcl-2-like protein 7</Alias>
      <Alias>Pro-apoptotic protein BAK</Alias>
      <Alias>Bcl2-L-7</Alias>
      <Alias>Apoptosis regulator BAK</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.</Detail>
      <Keyword>Protein heterodimerization activity</Keyword>
      <Ontology_ID>GO:0046982</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>42</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The conversion of proteins that induce or sustain apoptosis to an active form.</Detail>
      <Keyword>Activation of pro-apoptotic gene products</Keyword>
      <Ontology_ID>GO:0008633</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer.</Detail>
      <Keyword>Regulation of protein heterodimerization activity</Keyword>
      <Ontology_ID>GO:0043497</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Establishment or maintenance of transmembrane electrochemical gradient</Keyword>
      <Ontology_ID>GO:0010248</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.</Detail>
      <Keyword>Cellular response to mechanical stimulus</Keyword>
      <Ontology_ID>GO:0071260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by intracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by intracellular signals</Keyword>
      <Ontology_ID>GO:0008629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.</Detail>
      <Keyword>Regulation of mitochondrial membrane potential</Keyword>
      <Ontology_ID>GO:0051881</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.</Detail>
      <Keyword>Regulation of mitochondrial membrane permeability</Keyword>
      <Ontology_ID>GO:0046902</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.</Detail>
      <Keyword>Regulation of protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0043496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by extracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by extracellular signals</Keyword>
      <Ontology_ID>GO:0008624</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.</Detail>
      <Keyword>Cellular response to UV</Keyword>
      <Ontology_ID>GO:0034644</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.</Detail>
      <Keyword>Release of cytochrome c from mitochondria</Keyword>
      <Ontology_ID>GO:0001836</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MASGQGPGPPRQECGEPALPSASEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAALNLGNGPILNVLVVLGVVLLGQFVVRRFFKS</Protein_Seq>
    <DNA_Seq>ACAGGGACAAGTAAAGGCTACATCCAGATGCCGGGAATGCACTGACGCCCATTCCTGGAAACTGGGCTCCCACTCAGCCCCTGGGAGCAGCAGCCGCCAGCCCCTCGGGACCTCCATCTCCACCCTGCTGAGCCACCCGGGTTGGGCCAGGATCCCGGCAGGCTGATCCCGTCCTCCACTGAGACCTGAAAAATGGCTTCGGGGCAAGGCCCAGGTCCTCCCAGGCAGGAGTGCGGAGAGCCTGCCCTGCCCTCTGCTTCTGAGGAGCAGGTAGCCCAGGACACAGAGGAGGTTTTCCGCAGCTACGTTTTTTACCGCCATCAGCAGGAACAGGAGGCTGAAGGGGTGGCTGCCCCTGCCGACCCAGAGATGGTCACCTTACCTCTGCAACCTAGCAGCACCATGGGGCAGGTGGGACGGCAGCTCGCCATCATCGGGGACGACATCAACCGACGCTATGACTCAGAGTTCCAGACCATGTTGCAGCACCTGCAGCCCACGGCAGAGAATGCCTATGAGTACTTCACCAAGATTGCCACCAGCCTGTTTGAGAGTGGCATCAATTGGGGCCGTGTGGTGGCTCTTCTGGGCTTCGGCTACCGTCTGGCCCTACACGTCTACCAGCATGGCCTGACTGGCTTCCTAGGCCAGGTGACCCGCTTCGTGGTCGACTTCATGCTGCATCACTGCATTGCCCGGTGGATTGCACAGAGGGGTGGCTGGGTGGCAGCCCTGAACTTGGGCAATGGTCCCATCCTGAACGTGCTGGTGGTTCTGGGTGTGGTTCTGTTGGGCCAGTTTGTGGTACGAAGATTCTTCAAATCATGACTCCCAAGGGTGCCCTTTGGGTCCCGGTTCAGACCCCTGCCTGGACTTAAGCGAAGTCTTTGCCTTCTCTGTTCCCTTGCAGGGGTCCCCCCTCAAGAGTACAGAAGCTTTAGCAAGTGTGCACTCCAGCTTCGGAGGGCCCCTGCGTGGGGGCAGTCAGGCTGCAGAGGCACCTCAACATTGCATGGTGCTAGTGGGCCCTCTCTCTGGGCCAGGGGTGTGCCGTCTCCTCCCTCAGCTCTCTGGGACCTCCTTAAACCCTGTCCTGCTAGGCGCTGGGGAGACTGATAACTTGGGGAGACAAGAGACTGGGACCCACTTCTCCCCAGGAAGTGTTTAACGGTTTTAGCTTTTTATAATACCCTTGTGAGAGCCCATTCCCACCATTCTACCTGAGGCCAGGACGTCTGGGGTGTGGGGATTGGTGGGTCTATGTTCCCCAGGATTCAGCTATTCTGGAAGATCAGCACCCTAAGAGATGGGACTAGGACCTGATCCTGGTCCTGGCCGTCCCTAAGCATGTGTCCCAGGG</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Heart</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>BAK1</Gene_Name>
    <Gene_Alias>BAK; BCL2L7; CDN1</Gene_Alias>
    <Gene_ID>578</Gene_ID>
    <Genbank_ACCN>NM_001188</Genbank_ACCN>
    <Protein_ACCN>NP_001179</Protein_ACCN>
    <HGNC_ID>949</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/578</Gene_URL>
    <UCSC_ID>uc003oer.3</UCSC_ID>
    <EMBL_ID>ENSG00000030110</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q16611</Uniprot_ID>
      <Gene_Name>BAK1</Gene_Name>
      <EBI_ID>EBI-519866</EBI_ID>
      <PPI_EBI_URL>EBI-519866,EBI-519866</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07820</Uniprot_ID>
      <Gene_Name>MCL1</Gene_Name>
      <EBI_ID>EBI-1003422</EBI_ID>
      <PPI_EBI_URL>EBI-519866,EBI-1003422</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07817</Uniprot_ID>
      <Gene_Name>BCL2L1</Gene_Name>
      <EBI_ID>EBI-78035</EBI_ID>
      <PPI_EBI_URL>EBI-519866,EBI-78035</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P97287</Uniprot_ID>
      <Gene_Name>Mcl1</Gene_Name>
      <EBI_ID>EBI-707292</EBI_ID>
      <PPI_EBI_URL>EBI-519866,EBI-707292</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07817-1</Uniprot_ID>
      <Gene_Name>BCL2L1</Gene_Name>
      <EBI_ID>EBI-287195</EBI_ID>
      <PPI_EBI_URL>EBI-519866,EBI-287195</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Telangiectasis</Disease_Name>
      <Disease_Detail>Telangiectasis</Disease_Detail>
      <Disease_DB>TLN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/telangiectasis?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Lymphocytic Leukemia</Disease_Name>
      <Disease_Detail>Chronic Lymphocytic Leukemia</Disease_Detail>
      <Disease_DB>CHR090</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_lymphocytic_leukemia?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Odontogenic Myxoma</Disease_Name>
      <Disease_Detail>Odontogenic Myxoma</Disease_Detail>
      <Disease_DB>ODN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/odontogenic_myxoma?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cervical Cancer</Disease_Name>
      <Disease_Detail>Cervical Cancer</Disease_Detail>
      <Disease_DB>CRV035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cervical_cancer?search=BAK1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benign Mammary Dysplasia</Disease_Name>
      <Disease_Detail>Benign Mammary Dysplasia</Disease_Detail>
      <Disease_DB>BNG025</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_mammary_dysplasia?search=BAK1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site</PDB_Title>
      <PDB_ID>2IMT</PDB_ID>
      <Resolution>1.49</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IMT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site.</PubMed_Title>
      <Author>Moldoveanu T, et al.</Author>
      <Journal>Mol Cell. 2006 Dec 8;24(5):677-88.</Journal>
      <PubMed_ID>17157251</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site</PDB_Title>
      <PDB_ID>2IMS</PDB_ID>
      <Resolution>1.48</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IMT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site.</PubMed_Title>
      <Author>Moldoveanu T, et al.</Author>
      <Journal>Mol Cell. 2006 Dec 8;24(5):677-88.</Journal>
      <PubMed_ID>http://www.pdb.org/pdb/explore/explore.do?structureId=2IMS</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>1BXL</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BXL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.</PubMed_Title>
      <Author>Sattler M, et al.</Author>
      <Journal>Science. 1997 Feb 14;275(5302):983-6.</Journal>
      <PubMed_ID>9020082</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A VIRAL PROTEIN UNEXPECTEDLY MIMICS THE STRUCTURE AND FUNCTION OF PRO-SURVIVAL BCL-2</PDB_Title>
      <PDB_ID>2JBY</PDB_ID>
      <Resolution>2.41</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JBY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak.</PubMed_Title>
      <Author>Kvansakul M, et al.</Author>
      <Journal>Mol Cell. 2007 Mar 23;25(6):933-42.</Journal>
      <PubMed_ID>17386268</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human Bcl-2 family protein Bak</PDB_Title>
      <PDB_ID>2YV6</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2YV6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator.</PubMed_Title>
      <Author>Wang H, et al.</Author>
      <Journal>J Struct Biol. 2009 Apr;166(1):32-7.</Journal>
      <PubMed_ID>19135534</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE CRYSTAL STRUCTURE OF BAK1 - A MITOCHONDRIAL APOPTOSIS REGULATOR</PDB_Title>
      <PDB_ID>2JCN</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JCN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Crystal Structure of Bak1 - an Apoptosis Trigger in the Mitochondrial Outer Membrane</PubMed_Title>
      <Author>Moche M, et al.</Author>
      <Journal>to be published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human BFL-1 in complex with BAK BH3 peptide</PDB_Title>
      <PDB_ID>3I1H</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3I1H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>crystal structure of human BFL-1 in complex with BAK BH3 peptide</PubMed_Title>
      <Author>Guan R, et al.</Author>
      <Journal>to be published</Journal>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_URL>http://www.cathdb.info/pdb/2yv6</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Korsmeyer SJ, et al. Cell Death Differ. 2000,7(12):1166-1173.</Site_Reference>
      <Site_Type>Protein-induced</Site_Type>
      <PubMed_ID>11175253</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>